October 24, 2017 / 3:35 PM / 2 months ago

UPDATE 1-Cargill to buy feed maker in high-margin natural foods push

(New throughout, adds background, deal size comparison, comment from executive, byline)

By Karl Plume

CHICAGO, Oct 24 (Reuters) - Global commodities trader Cargill Inc on Tuesday said it was buying a natural animal feed maker, another in a string of deals to capitalize on rising demand for higher-margin natural foods and antibiotic-free meat and dairy products.

Privately held Cargill’s recent push, including Tuesday’s deal for Iowa-based Diamond V, has centered on its animal nutrition and protein unit, with expansions in feed production and aquaculture and divestitures of its U.S. pork business and cattle feedlots.

Cargill and rivals like Archer Daniels Midland Co, Bunge Ltd and Louis Dreyfus Co, known as the ABCD quartet of global grain trading giants, have moved to diversify amid a global grains glut that has weighed on margins and dragged profits.

The deal, expected to close in January, is Cargill’s latest investment in its animal nutrition and protein segment, which has posted higher profits in five straight quarters and is a major focus of the company’s long-term growth strategy.

“We anticipate that we will continue to invest in this space,” Chuck Warta, president of Cargill’s premix and nutrition business told Reuters.

Cargill invested in feed additive company Delacon in July, bought the animal feed business of U.S. farm cooperative Southern States in August and expanded feed milling in Thailand in September.

“This space of micronutrition and feed additives around the world, that’s about a $20 billion market. Delacon and Diamond V are our initial investments into this,” Warta said.

Cargill did not disclose terms of the Diamond V deal, but said it was among the five largest acquisitions in the company’s 152-year history.

Among those deals were a $1.5 billion acquisition of Norwegian fish feed company EWOS and a $1.2 billion deal in 2008 for starch manufacturer Cerestar.

Diamond V is also privately held and does no disclose its revenue. The deal includes Diamond V’s human health business Embria Health Sciences, which produces ingredients for dietary supplements. (Additional reporting by Anirban Paul in Bengaluru; Editing by Supriya Kurane)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below